Live Analyst Rating Changes 1348 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Bradley Bowers
MIZU
Bradley Bowers
Wall Street Analyst
★★★★☆
#506
on 13Foresight · ranked by our own returns
75%
Success Rate
+15.4%
Average Return
3 of 4 calls profitable · +9.2% vs benchmark
📈 Across the calls we could measure, roughly 75% of Bradley Bowers's ratings turned a profit when each position was held for 1 year — averaging +15.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

9 Buy 2 Hold 0 Sell
Bradley's Stock Coverage 3 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
GH
Guardant Health
Jun 08, 2026 BUY Strong Buy
-5.0% avg upside
30 analysts
$175.00
31.84% Upside
+4.0%
GRAL
GRAIL Inc
Apr 13, 2026 HOLD Buy
+6.5% avg upside
8 analysts
$58.00
6.74% Downside
+21.3%
TEM
Tempus AI, Inc. Class A
Feb 19, 2026 BUY Strong Buy
+37.5% avg upside
19 analysts
$100.00
101.16% Upside
-15.7%
Bradley Bowers — Frequently Asked Questions
How accurate are Bradley Bowers's stock ratings?
Based on the calls 13Foresight could measure, about 75% of Bradley's ratings were profitable over a one-year hold, with an average return of +15.4% per rating, or +9.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Bradley ranked on 13Foresight?
Bradley Bowers is currently ranked #506 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Bradley cover?
Bradley most recently has ratings on GH, GRAL, TEM. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.